More Than 100 Bristol-Myers Squibb Employees Embark on Coast 2 Coast 4 Cancer Ride to Help Advance Groundbreaking Cancer Re...
September 04 2019 - 6:00AM
Business Wire
10-year cancer survivor Dana Vaughns
joins colleagues in cross-country cycling relay with a goal to
raise more than $1 million for the V Foundation for Cancer
Research
Bristol-Myers Squibb Company (NYSE:BMY) employee Dana Vaughns
will celebrate his 10-year anniversary of surviving bone cancer by
taking on the physical challenge of his life. Today, he and more
than 100 of his colleagues are kicking off the annual Coast 2 Coast
4 Cancer ride, a nearly 3,000-mile cycling relay that benefits the
V Foundation for Cancer Research.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20190904005291/en/
Dana Vaughns will ride Coast 2 Coast 4
Cancer to celebrate his 10-year anniversary of overcoming bone
cancer (Photo: Business Wire)
“For me, this ride is a symbol of my victory over cancer,” said
Vaughns. “I was able to put cancer in my rear-view mirror, but
there are so many people out there with a long road ahead of them.
Over the next three days, I’m riding for all those who know what
it’s like to hear the words, ‘You have cancer.’ Hopefully, with the
help of the V Foundation’s research, more people can someday hear
the words, ‘You are cancer-free.’”
For the sixth year in a row, Coast 2 Coast 4 Cancer will begin
in Cannon Beach, Oregon, with each team of novice cyclists riding
for three days until they finish the journey on September 24 in
Long Branch, New Jersey. Along the way, the riders will strive to
reach their goal of raising more than $1 million for the V
Foundation. Bristol-Myers Squibb will match donations,
dollar-for-dollar, up to $500,000.
“Even in a time of rapid progress, we know there are still
breakthroughs waiting to be discovered, which is what drives our
commitment to funding scientists at the cutting edge of research
and care,” said Susan Braun, chief executive officer of the V
Foundation for Cancer Research. “Our philosophy is to never give up
on our quest to defeat cancer, and we see that same spirit in all
of the dedicated Bristol-Myers Squibb cyclists who are riding Coast
2 Coast 4 Cancer. We are honored to be the recipient of their hard
work, sacrifice and determination.”
“At Bristol-Myers Squibb, we work every day to help patients
overcome serious diseases like cancer, but we can’t do it by
ourselves. That’s why we’re supporting the V Foundation’s
groundbreaking research through this ride,” said Susan Sweeney,
president and head of U.S. Commercial, Bristol-Myers Squibb. “We
often say that Coast 2 Coast 4 Cancer is more than a bike ride
because its impact stretches beyond the 3,000 miles the riders
cover. We’re out there on the road for every single person living
with cancer, every loved one supporting a patient, and every friend
and family member we’ve lost to this disease.”
Each of this year’s 109 Coast 2 Coast 4 Cancer riders will cover
approximately 225 miles of diverse terrain, facing varying weather
conditions. One team will pedal across the wind-swept plains of
central Kansas, while another team will take on the steepest ascent
of the journey as they climb the Appalachian Mountains and head for
the finish line at the New Jersey shore. For the last five months,
the riders trained extensively to rise to this challenge, all with
their own personal motivations and stories.
Bristol-Myers Squibb colleagues from across Europe will also
show their commitment to cancer research by embarking on the fourth
annual Country 2 Country 4 Cancer ride from September 9-26. Six
teams with members from 15 countries have committed to going the
distance in this year’s ride, which covers approximately 3,600
kilometers (2,236 miles). Riders will cycle across Europe from
Germany, through Switzerland, Italy, France and Spain, with the
final team finishing in the U.K. Funds raised will support
market-specific, cancer-focused charities in Europe.
For more information, or to support the riders in the 2019 Coast
2 Coast 4 Cancer ride, please visit cancerbikeride.org or follow
the ride on Facebook, Twitter and LinkedIn by using #C2C4C.
About Bristol-Myers Squibb
Company
Bristol-Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop, and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol-Myers Squibb, visit us at bms.com or
follow us on LinkedIn, Twitter, YouTube, and Facebook.
About the V Foundation for Cancer
Research
The V Foundation for Cancer Research was founded in 1993 by ESPN
and the late Jim Valvano, legendary North Carolina State basketball
coach and ESPN commentator. Since 1993, the Foundation has funded
more than $225 million in cancer research grants nationwide. The V
Foundation awards 100 percent of direct donations to cancer
research and programs. The V Foundation’s endowment covers
administrative expenses. The Foundation awards peer-reviewed grants
through a competitive awards process strictly supervised by a
Scientific Advisory Committee. For more information on the V
Foundation or to make a donation, please visit v.org.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190904005291/en/
Bristol-Myers Squibb Company Heather Acker 973-713-6137
Heather.acker@bms.com
OR
Jessica Horton 609-577-5644 jessica.horton@bms.com
The V Foundation Missy White 919-805-0767
missy@intrepidmg.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2024 to May 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From May 2023 to May 2024